A cursory look at the current status of the FDA’s quality-by-design (QbD) initiative reveals a mixed picture. By mid-2009, early adopters had successfully employed QbD tools to file FDA applications. Other companies cherry-picked the tools while contemplating if and how to expand their piecemeal approaches.
No comments:
Post a Comment